1-[(3-Chlorophenyl)methyl]-6-(4-methoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile

Catalog No. :
ACMKPM401
CAS No. :
252060-09-6
Molecular Formula :
C20H15ClN2O2
Molecular Weight :
350.80

IUPAC Name:1-(3-chlorobenzyl)-6-(4-methoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile

1-[(3-Chlorophenyl)methyl]-6-(4-methoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$496.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(3-Chlorophenyl)methyl]-6-(4-methoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile
IUPAC Name1-(3-chlorobenzyl)-6-(4-methoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile
MDL No.MFCD00215104
Molecular FormulaC20H15ClN2O2
Molecular Weight350.80
SMILESN#CC1=CC=C(C2=CC=C(OC)C=C2)N(CC3=CC=CC(Cl)=C3)C1=O
InChI KeyOMWCLBBWESTGIC-UHFFFAOYSA-N
Synonym1-(3-CHLOROBENZYL)-6-(4-METHOXYPHENYL)-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBONITRILE;3-Pyridinecarbonitrile, 1-[(3-chlorophenyl)methyl]-1,2-dihydro-6-(4-methoxyphenyl)-2-oxo-
CAS No.252060-09-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMKPM401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMKPM401 route product structure diagram
    ACMKPM401252060-09-6
Inquiry

2. ACMKPM401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMKPM401 route product structure diagram
    ACMKPM401252060-09-6
Inquiry

Comments (0)